Arcus Biosciences (RCUS) FCF Margin Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arcus Biosciences | 3.73 Bn | 2.90 Bn | - | -33,676.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,676.00 |
| Dec 31, 2025 | -513.00 |
| Sep 30, 2025 | -46,891.00 |
| Jun 30, 2025 | 16,559.00 |
| Mar 31, 2025 | -47,293.00 |
| Dec 31, 2024 | 35,275.00 |
| Sep 30, 2024 | 30,521.00 |
| Jun 30, 2024 | -5,217.00 |
| Mar 31, 2024 | 42,193.00 |
| Dec 31, 2023 | -50,252.00 |
| Sep 30, 2023 | 4,517.00 |
| Jun 30, 2023 | 3,678.00 |
| Mar 31, 2023 | -404,067.00 |
| Dec 31, 2022 | -19,475.00 |
| Sep 30, 2022 | 36,730.00 |
| Jun 30, 2022 | 51,437.00 |
| Mar 31, 2022 | 434,703.00 |
| Dec 31, 2021 | 52,770.00 |
| Sep 30, 2021 | -95,507.00 |
| Jun 30, 2021 | 61,596.00 |